
Article 1 
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 30 August 2017.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2018’;
((2)) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2018’;
((3)) in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by ‘31 October 2018’;
((4)) in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2018’;
((5)) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2018’;
((6)) in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by ‘31 October 2018’;
((7)) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2018’;
((8)) in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by ‘31 October 2018’;
((9)) in the sixth column, expiration of approval, of row 101, Chlorothalonil, the date is replaced by ‘31 October 2018’;
((10)) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2018’;
((11)) in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2018’;
((12)) in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2018’;
((13)) in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2018’;
((14)) in the sixth column, expiration of approval, of row 106, Tribenuron, the date is replaced by ‘31 October 2018’;
((15)) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2018’;
((16)) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2018’;
((17)) in the sixth column, expiration of approval, of row 117, 1-methylcyclopropene, the date is replaced by ‘31 October 2018’;
((18)) in the sixth column, expiration of approval, of row 118, Forchlorfenuron, the date is replaced by ‘31 October 2018’;
((19)) in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2018’.
